StockpollyBeta
Get App
Popularity #1,348
VOR · NASDAQ · Biotechnology

Vor Biopharma (VOR)

Develops licensed telitacicept for autoimmune diseases outside Greater China.

$22.00
After hours+0.01 (+0.05%)
At close$21.99(+0.46%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Cost of revenue011101000000
Gross profit0−1−1−10−1000000
3527312829303327428363548
Research & development2821242222252726114191826
8676757214171822
Selling & marketing00−1−100000000
General & administrative8087707214171822
Other expenses0000000100000
Operating income−35−28−32−29−29−31−33−274−28−36−35−48
2221111−1,299−7851,759−184−15
Interest income222111112344
Other non-operating income0−2−2−1−1−1−1−31785−1,7591840
Income before tax−33−26−31−28−28−31−32−1,574−8131,723−220−63
Net income from continuing operations−33−26−31−28−28−31−32−1,574−8131,723−220−63
Net income−33−26−31−28−28−31−32−1,574−8131,723−220−63
EPS, basic−$9.80−$7.80−$9.00−$8.20−$8.00−$9.00−$5.20−$251.20−$121.63$307.53−$510.53−$1.16
EPS, diluted−$9.80−$7.80−$9.00−$8.20−$8.00−$9.00−$5.20−$251.20−$121.63$44.50−$510.53−$1.16
Weighted average shares, basic33333366710054
Weighted average shares, diluted33333366710054
EBITDA−34−25−30−27−27−30−32−242−8131,723−220−48
Depreciation & amortization111111120000
EBIT−35−26−31−28−28−31−32−244−8131,723−220−48